Aimed Alliance Op-Ed on Precision Medicine is Featured in The Hill
Today, The Hill published Aimed Alliance’s op-ed, “Precision Medicine is a Game-Changer if Patients Get…
Author Aimed Alliance
Preserving a Balance of Exclusivity
Preserving a balance of exclusivity and protection poses more of a challenge for biologic drugs…
States Need Proper Substitution Laws in Place
The U.S. Food and Drug Administration (“FDA”) is preparing to approve the first follow-on biologic…
“I Am (Still) Essential” Coalition Applauds Proposed Changes to EHBs and Makes Suggestions To Increase Positive Patient Outcomes
Today, the “I Am (Still) Essential” coalition of patient groups sent a letter signed by…
Aimed Alliance Op-Ed: Fifty Million Life-Years Saved Through Medical Innovation
The Hill published an op-ed on the value of medical innovation, authored by Aimed Alliance’s Public…
Aimed Alliance Op-Ed on Providing an Honest Discussion of Costs of Cancer Treatment
An op-ed regarding the need for an honest discussion of the costs of cancer treatment,…
Time Reports on the Easiest Way To Beat Health Care Costs in Retirement
According to Time, out-of-pocket health care costs can total the average retiree $318,000. Moreover, longer life…
The Hill Publishes Aimed Alliance Op-Ed Dispeling the Myths about Specialty Medicine Costs
On June 25, 2014, the Hill published Exploding Big Myths About the Cost of Innovative Therapies,…
Quinnipiac Health Law Journal Publishes Aimed Alliance Article on Biologics
Quinnipiac University School of Law recently released its most recent volume of the Health Law…
Using Data To Improve Future Cancer Treatments
A new initiative called CancerLinQ will collect and analyze massive amounts of data to provide…